Avior Wealth Management, LLC

Position in PCVX — Vaxcyte, Inc.

CIK 1599868 OMAHA, NE

Position in PCVX

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$333,898

-$168,579 QoQ

Shares Held

5,744

-33.6% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#209

of 329 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Avior Wealth Management, LLC holds $5,109,937 across 10 Biotechnology names. PCVX ranks #6 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,045	$1,512,542
2	REGN	Regeneron Pharmaceuticals, Inc.	1,358	$846,767
3	RYTM	Rhythm Pharmaceuticals, Inc.	5,440	$604,003
4	INSM	INSMED Inc	4,913	$523,824
5	ABVX	Abivax S.A.	3,037	$404,710
6	PCVX	Vaxcyte, Inc. This page	5,744	$333,898
7	RVMD	Revolution Medicines, Inc.	1,769	$331,298
8	PTCT	Ptc Therapeutics, Inc.	3,780	$308,334

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$333,898	5,744	-33.6%	Shares	Sole	2026-07-07
2026-03-31	$502,477	8,647	-8.9%	Shares	Sole	2026-04-09
2025-12-31	$437,730	9,487	-14.0%	Shares	Sole	2026-01-06
2025-09-30	$397,336	11,031	+29.3%	Shares	Sole	2025-11-14
2025-06-30	$277,277	8,529	+25.4%	Shares	Sole	2025-07-17
2025-03-31	$256,730	6,799	+5.3%	Shares	Sole	2025-04-21
2024-12-31	$528,488	6,456	+21.1%	Shares	Sole	2025-01-17
2024-09-30	$609,287	5,332	-8.6%	Shares	Sole	2024-11-08
2024-06-30	$440,298	5,831	+24.0%	Shares	Sole	2024-08-13
2024-03-31	$321,193	4,702	+0.7%	Shares	Sole	2024-04-30
2023-12-31	$293,276	4,670	+33.9%	Shares	Sole	2024-01-30
2023-09-30	$177,767	3,487	—	Shares	Sole	2023-10-17
No filing history on record for this holder in this stock.